Abstract:An overview of this research roadmap. We calculated the HAs by analyzing the expression levels of histone acetylation‐related genes. Kaplan–Meier survival analysis was performed to evaluate the prognostic value of the HAs. Furthermore, correlation analysis and differential expression analysis were conducted to assess the relationship between the HAs and key genes involved in histone acetylation regulation, as well as the expression differences of immune checkpoint genes. Objectives The purpose of this research was to study the impact of histone acetylation on glioblastoma multiforme (GBM) and lower‐grade gliomas (LGG) and its potential implications for patient prognosis. We aimed to assess the histone acetylation score (HAs) and its relationship with key genes involved in histone acetylation regulation. Method The TCGA‐GBMLGG dataset, which provides comprehensive genomic and clinical information, was utilized for this study. We calculated the HAs by analyzing the expression levels of histone acetylation‐related genes, including histone acetyltransferases and histone deacetylases, in GBM and LGG patients. Kaplan–Meier survival analysis was performed to evaluate the prognostic value of the HAs. Furthermore, correlation analysis and differential expression analysis were conducted to assess the relationship between the HAs and key genes involved in histone acetylation regulation, as well as the expression differences of immune checkpoint genes. Results Our analysis revealed a significant association between the HAs and patient prognosis, with higher HAs correlating to poorer outcomes in GBM and LGG patients. We observed a positive correlation between the HAs and key genes involved in histone acetylation regulation, indicating their potential role in modulating histone acetylation levels. Moreover, we found significant expression differences for immune checkpoint genes between high and low HAs groups, suggesting a potential impact of histone acetylation on the immune response in GBM and LGG. Conclusion This study highlights the significance of histone acetylation in GBM and LGG. The HAs demonstrated prognostic value, indicating its potential as a clinically relevant biomarker. The correlation between the HAs and key genes involved in histone acetylation regulation provides insights into the underlying mechanisms driving histone acetylation dysregulation in GBM and LGG. Furthermore, the observed expression differences of immune checkpoint genes suggest a potential link between histone acetylation and the immune response. These findings contribute to our understanding of the molecular basis of GBM and LGG and have implications for personalized treatment approaches targeting histone acetylation and the immune microenvironment. Further validation and functional studies are needed to confirm these findings and explore potential therapeutic strategies.

The relationship among histone deacety lases 3、 tumor grade and prognosis of children's gliomas

The Novel Histone Deacetylase Inhibitor Pracinostat Suppresses the Malignant Phenotype in Human Glioma

Expression and significance of vascuIar endothelial growth factor and Ⅷ-R Ag in human brain glioma

Histone Deacetylase 3 Participates in Growth and Migration of Glioma Cells

Histological and Molecular Classifications of Pediatric Glioma with Time-Dependent Diffusion MRI-based Microstructural Mapping.

The factors effecting on the prognosis of WHO grade Ⅲ glioma

A Multivariate Analysis of the Prognostic Factors of Grade III Gliomas

Pathological Significance of Epidermal Growth Factor Receptor Expression and Amplification in Human Gliomas

Prognostic value of H3K27me3 in children with ependymoma

Comprehensive analysis of histone acetylation‐related genes in glioblastoma and lower‐grade gliomas: Insights into drug sensitivity, molecular subtypes, immune infiltration, and prognosis

Prognostic factors for patients with glioma located in brain eloquent areas

ELK3: A New Molecular Marker for the Diagnosis and Prognosis of Glioma

The application of histone deacetylases inhibitors in glioblastoma

Histone Deacetylase HDAC4 Promotes the Proliferation and Invasion of Glioma Cells.

Identification Of Histone Acetylation-Related Enzymes As A Prognostic Indicator In Human Glioma

Identification of Histone Deacetylase 3 As a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-associated Hepatocellular Carcinoma.

The Expression of Histone Deacetylase HDAC1 Correlates with the Progression and Prognosis of Gastrointestinal Malignancy

Expression and Regulation Network of HDAC3 in Acute Myeloid Leukemia and the Implication for Targeted Therapy Based on Multidataset Data Mining

PBX3 as a biomarker for the early diagnosis and prediction of prognosis of glioma

Expression and potential application of histone deacetylase in prostate cancer

Prognostic Implications of Epidermal Growth Factor Receptor Variant III Expression and Nuclear Translocation in Chinese Human Gliomas